Over the past year, we have witnessed rapid geopolitical shifts, stronger domestic priorities in the United States, and new questions about multilateral cooperation (UN/WHO). This provides a valuable backdrop for discussing how the Nordic countries and Europe can strengthen cooperation, preparedness, and competitiveness within the pharmaceutical and MedTech industries – while maintaining a constructive relationship with the United States.

The participants are:

• Adam Cwejman, political editor at Göteborgs-Posten
• Christine Wergeland Sørbye, CEO Oslo Science City
• Kåre R. Aas, former ambassador to the United States, Afghanistan, and Israel
• Leif Rune Skymoen, CEO Association of the Pharmaceutical Industry in Norway (LMI)
• Peter Asplund, senior life science executive and seasoned leader with longstanding experience within clinical drug development
• Sara Lowemark, Head of International Relations at the Swedish Association of the Pharmaceutical Industry (Lif)
• Ylva Williams is CEO of the Stockholm Science City Foundation (SSCi)